[Benefit from bio-enteric Intra-gastric balloon (BIB) to modify lifestyle and eating habits in severely obese patients eligible for bariatric surgery]
- PMID: 16565699
[Benefit from bio-enteric Intra-gastric balloon (BIB) to modify lifestyle and eating habits in severely obese patients eligible for bariatric surgery]
Abstract
Aim: The therapeutic model for severe obesity includes bariatric surgery, representing the safest way to keep weight down and to prevent relapses. The selection of patients for the most suitable type of surgery implies multidisciplinary approach (nutritionist, dietist, clinical psychologist and surgeon). The intragastric balloon may represent a relatively invasive method to help the medical team to select and prepare severely obese patients for restrictive bariatric surgery.
Methods: In our study we considered 48 severely obese patients: initial weight 111+/-14.8 kg, BMI 43+/-5.02, excess weight 77.47+/-16.14%. These patients have been treated with intragastric balloon (BIB) filled to a volume of 500 cc for 6 months. We considered variations induced by BIB treatment on a number of parameters--clinical, anthropometric, food intake, partition of nourishing elements and psychological and psychometric data.
Results: At the end of the treatment the patients showed significant reductions of excess weight (67.35+/-20.19%), of weight (103.4+/-16.72 kg) and food intake, without modification of the items in the EDI2 test, but with important motivational support for a change in life style between the beginning and the end of the treatment, clearly resulting from the medical, dietist and clinical-psychological follow-up.
Conclusions: BIB is a relatively invasive means capable of modifying eating habits in the short term; it induces weight loss, may help to reduce the anaesthesiological risk and to foster a change in the patient's behaviour. In our experience treatment with BIB is useful from the educational point of view and can be used to select patients for bariatric surgery only within a multidisciplinary team. Further clinical studies are necessary.
Similar articles
-
Is bariatric surgery necessary after intragastric balloon treatment?Obes Surg. 2006 Sep;16(9):1135-7. doi: 10.1381/096089206778392365. Obes Surg. 2006. PMID: 16989695
-
The Bioenteric Intragastric Balloon (BIB) as a treatment for obesity: poor results in Asian patients.Singapore Med J. 2007 Mar;48(3):227-31. Singapore Med J. 2007. PMID: 17342292
-
BioEnterics Intragastric Balloon (BIB): a short-term, double-blind, randomised, controlled, crossover study on weight reduction in morbidly obese patients.Int J Obes (Lond). 2006 Jan;30(1):129-33. doi: 10.1038/sj.ijo.0803094. Int J Obes (Lond). 2006. PMID: 16189503 Clinical Trial.
-
[Intra gastric balloon for morbid obesity].Harefuah. 2006 Nov;145(11):826-30, 861. Harefuah. 2006. PMID: 17183956 Review. Hebrew.
-
Position of intragastric balloons in global initiative for obesity treatment.Coll Antropol. 2011 Dec;35(4):1353-62. Coll Antropol. 2011. PMID: 22397287 Review.
Cited by
-
Single vs repeated treatment with the intragastric balloon: a 5-year weight loss study.Obes Surg. 2010 Jun;20(6):692-7. doi: 10.1007/s11695-010-0127-x. Obes Surg. 2010. PMID: 20352524
-
Intragastric balloon treatment for obesity: results of a large single center prospective study.Obes Surg. 2011 May;21(5):551-5. doi: 10.1007/s11695-010-0310-0. Obes Surg. 2011. PMID: 21170685
-
Intragastric balloon treatment of obesity: Long-term results and patient satisfaction.Turk J Gastroenterol. 2019 May;30(5):461-466. doi: 10.5152/tjg.2019.17877. Turk J Gastroenterol. 2019. PMID: 31061001 Free PMC article.
-
Tolerance and efficacy of an air-filled balloon in non-morbidly obese patients: results of a prospective multicenter study.Obes Surg. 2007 Jun;17(6):764-9. doi: 10.1007/s11695-007-9141-z. Obes Surg. 2007. PMID: 17879576 Clinical Trial.
-
Impact of a 6-month treatment with intragastric balloon on body composition and psychopathological profile in obese individuals with metabolic syndrome.Diabetol Metab Syndr. 2016 Dec 19;8:81. doi: 10.1186/s13098-016-0197-6. eCollection 2016. Diabetol Metab Syndr. 2016. PMID: 28031749 Free PMC article.